Catheter lock solution comprising citrate and a paraben
View Patent ↗This invention relates to compositions, methods, devices and kits relating to the infusion of a catheter lock solution into an indwelling catheter. Inventive compositions, methods, devices and kits aid in diminishing the effects of microbial infection in catheters and occlusion of the catheters. A lock solution provided by the invention includes citrate and a paraben. The solution preferably has a density suitable for retention of the solution in a catheter during the lock period. Another lock solution provided by the invention includes citrate, a paraben and a photo-oxidant, such as, for example, methylene blue.
1. A method of inhibiting infection in an indwelling
catheter defining at least one lumen therethrough, the method comprising infusing an aqueous catheter lock solution into a lumen of the catheter, the solution comprising citrate, methylene blue and a paraben dispersed or dissolved therein.
2. The method of claim 1 wherein the catheter is an intravascular catheter or a body cavity catheter.
3. The method of claim 1 wherein the lumen of the catheter has an internal volume and the method comprises infusing an amount of the lock solution that is from about 80% to about 120% of the internal volume of the lumen.
4. The method according to claim 1 wherein the paraben is methyl paraben, ethyl paraben, propyl paraben, butyl paraben, or a combination thereof.
5. The method according to claim 1 wherein the solution comprises methyl paraben.
6. The method according to claim 5 wherein the concentration of methyl paraben in the solution is from about 0.005 to about 0.5 percent.
7. The method according to claim 1 wherein the solution comprises propyl paraben.
8. The method according to claim 7 wherein the concentration of propyl paraben in the solution is from about 0.005 to about 0.5 percent.
9. The method according to claim 1 wherein the solution comprises methyl paraben and propyl paraben.
10. The method according to claim 9 wherein the concentration of methyl paraben in the solution is from about 0.05 to about 0.5 percent and the concentration of propyl paraben in the solution is from about 0.005 to about 0.5 percent.
11. The method according to claim 1 wherein the concentration of citrate in the solution is at least as high as the calcium concentration in a patient's blood.
12. The method according to claim 1 wherein the concentration of citrate in the solution is from about 1.5 to about 47% by weight.
13. The method according to claim 1 wherein the concentration of citrate in the solution is from about 1.5 to about 23% by weight.
14. The method of according to claim 1 wherein the citrate has a concentration of from about 1.5 to about 15 percent and the paraben has a concentration of from about 0.005 to about 0.6 percent.
15. The method according to claim 1 wherein the citrate is trisodium citrate dihydrate.
16. The method according to claim 1 wherein the pH of the solution is from about 4 to about 8.
17. The method according to claim 1 wherein the relative density of the solution is from about 1.000 to about 1.300 g/ml.
18. The method according to claim 1 wherein the solution further comprises a viscosifying agent.
19. The method according to claim 18 wherein the viscosifying agent comprises dextran, polyethylene glycol, glycerin, polygeline, a non-metabolizable sugar, or a combination thereof.
20. The method according to claim 1 wherein the concentration of methylene blue in the solution is up to about 1500 mg/100 ml.
21. The method according to claim 1 , wherein the catheter is in a patient.
22. The method according to claim 21 , wherein the catheter is surgically implanted.